1. Scott, A. M., Allison, J. P., & Wolchok, J. D. (2012). Monoclonal antibodies in cancer therapy. Cancer Immunity Arch, 12, 1.
2. Nejadmoghaddam, M. R., Minai-Tehrani, A., Ghahremanzadeh, R., Mahmoudi, M., Dinarvand, R., & Zarnani, A. H. (2019). Antibody-drug conjugates: possibilities and challenges. Avicenna Journal of Medical Biotechnology, 11(1), 3.
3. Balkwill, F. R., Capasso, M., & Hagemann, T. (2012). The tumor microenvironment at a glance. Journal of Cell Science, 125(23), 5591–5596. https://doi.org/10.1242/jcs.116392.
4. Wang, M., Zhao, J., & Zhang, L., et al. (2017). Role of tumor microenvironment in tumorigenesis. Journal of Cancer, 8(5), 761.
5. Ostrand-Rosenberg, S., Horn, L. A., & Haile, S. T. (2014). The programmed death-1 immune-suppressive pathway: barrier to antitumor immunity. Journal of Immunology, 193(8), 3835–3841.